efficacy of sertraline, escitalopram in treatment of depression in patients undergoing chronic hemodialysis

Comparison of the efficacy of sertraline, escitalopram in treatment of depression in patients undergoing chronic hemodialysis

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210424051066N1

Enrollment

132

Registered

2021-05-23

Start date

2020-03-20

Completion date

Unknown

Last updated

2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression. F32

Interventions

Intervention 1: Intervention group: Escitalopram group, 1week under treatment with Escitalopream 10 mg and then increase doses of drug in 3 months to maximum dose of 20mg. Monitorig of patients one,tw

Eligibility

Sex/Gender

All

Age

21 Years to No maximum

Inclusion criteria

Inclusion criteria: Depression in chronic hemodialysis patients consent for study participation Age above 21

Exclusion criteria

Exclusion criteria: another psychologic problems in patients no drug compliance because of drug side effects data defects patients undergo another treatments patients with no follow up

Design outcomes

Primary

Measure	Time frame
Effect of SSRI drugs on Depression. Timepoint: one month- two months- three months. Method of measurement: Beck questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTahereh Sabaghian

Shahid Beheshti University of Medical Sciences

info@ehmc.ir+98 21 7343 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026